Correlation Between Apogee Therapeutics, and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Abcellera Biologics, you can compare the effects of market volatilities on Apogee Therapeutics, and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Abcellera Biologics.
Diversification Opportunities for Apogee Therapeutics, and Abcellera Biologics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Apogee and Abcellera is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Abcellera Biologics go up and down completely randomly.
Pair Corralation between Apogee Therapeutics, and Abcellera Biologics
Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the Abcellera Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Apogee Therapeutics, Common is 1.27 times less risky than Abcellera Biologics. The stock trades about -0.25 of its potential returns per unit of risk. The Abcellera Biologics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 289.00 in Abcellera Biologics on August 28, 2024 and sell it today you would earn a total of 6.00 from holding Abcellera Biologics or generate 2.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apogee Therapeutics, Common vs. Abcellera Biologics
Performance |
| Timeline |
| Apogee Therapeutics, |
| Abcellera Biologics |
Apogee Therapeutics, and Abcellera Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apogee Therapeutics, and Abcellera Biologics
The main advantage of trading using opposite Apogee Therapeutics, and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.| Apogee Therapeutics, vs. Bridgford Foods | Apogee Therapeutics, vs. Tyson Foods | Apogee Therapeutics, vs. Iridium Communications | Apogee Therapeutics, vs. Natural Alternatives International |
| Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets |